← All trials
NCT03284814
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 19, 2017
- Primary completion
- Oct 20, 2018
- Completion date
- Oct 20, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 21
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Nutrition Institute, SloveniaLead sponsor
- Valens Int. d.o.o., SlovenijaOverall official - principal investigator
- Valens Int. d.o.o., SlovenijaCollaborator
- Nutrition Institute, LjubljanaOverall official - principal investigator
- Nutrition Institute, SloveniaReponsible party - principal investigator
- VizeraCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.